Annals of Surgical Oncology · 2019 · 44 citations · 20 references
MedicineOncologySurgeryBreast OncologyChemotherapySurgical OncologyBreast Cancer RecurrenceBreast SurgeryBreast-conserving TherapyMargin AssessmentNeoadjuvant ChemotherapyTumor MarginsClose Surgical MarginsNegative Surgical MarginsOncologic Resection MarginsPositive Surgical MarginsPreoperative ChemotherapyRecurrence-free SurvivalSurgical Resection MarginsSurvival Rates
BACKGROUND: resection in primary surgery, it's unclear if it's oncologically safe after neoadjuvant chemotherapy (NAC). Only limited data demonstrate that surgery within new margins in cases of a pathological complete response (pCR) is safe. We therefore investigated the influence of different margins and pCR on local recurrence and survival rates after NAC. METHODS: We retrospectively analysed data of 406 women with invasive breast cancer, treated with NAC and breast-conserving therapy between 1994 and 2014 in two certified Austrian breast health centres. We compared R ≤ 1 mm, R > 1 mm and RX (pCR) for local recurrence-free survival (LRFS), disease-free survival (DFS) and overall survival (OS). RESULTS: After a median follow-up of 84.3 months, the 5-year LRFS (R ≤ 1 mm: 94.2%, R > 1 mm: 90.6%, RX: 95.0%; p = 0.940), the 5-year DFS (R ≤ 1 mm: 71.9%, R > 1 mm: 74.1%, RX: 87.2%; p = 0.245) and the 5-year OS (R ≤ 1 mm: 85.1%, R > 1 mm: 88.0%, RX: 96.4%; p = 0.236) did not differ significantly between narrow, wide, nor RX resections. Regarding DFS and OS, a negative nodal status reduced the hazard ratio significantly. CONCLUSION: There is no significant difference in LRFS, DFS and OS comparing close, wide or unknown margins after pCR. We suggest that resection in new margins after NAC is safe according to "no tumour on ink". Resection of the clipped area in cases of pCR is emphasized.
20
Laura J. Esserman, Donald A. Berry, Angela DeMichele et al. · Journal of Clinical Oncology · 2012 · 441 citations · Full text
Medicine, Biostatistics, Oncology +11
Chafika Mazouni, Florentia Peintinger, Shu Wan-Kau et al. · Journal of Clinical Oncology · 2007 · 308 citations · Full text
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian et al. · Journal of the National Comprehensive Cancer Network · 2015 · 182 citations